Vanguard Group Inc Lexaria Bioscience Corp. Put Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LEXX
# of Institutions
28Shares Held
2.05MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.02MShares$2.5 Million0.04% of portfolio
-
Invenomic Capital Management LP Boston, MA514KShares$1.26 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA115KShares$281,2180.0% of portfolio
-
Gen Trust, LLC60KShares$147,0000.01% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$110,0050.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $14.6M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...